v3.26.3
Consolidated Balance Sheets - USD ($)
Aug. 31, 2026
May 31, 2026
CURRENT ASSETS    
Cash and cash equivalents $ 32,474 $ 165,532
Accounts receivable 38,160 38,160
Prepaid investment 0 5,000
Total Current Assets 70,634 208,692
OTHER ASSETS    
Investment in Acquisition 2,500,000 2,500,000
Loans receivable, related party 222,337 35,237
Total Other Assets 2,722,337 2,535,237
TOTAL ASSETS 2,792,971 2,743,929
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 98,361 243,391
Accrued interest payable on notes payable 1,335,561 1,246,964
Accrued consulting fees 71,887 26,887
Notes payable 2,066,748 1,775,661
Notes payable to related parties 2,493,800 2,518,800
Derivative liability 6,168 2,158,096
Total Current Liabilities 6,072,525 7,969,799
TOTAL LIABILITIES 6,072,525 7,969,799
STOCKHOLDERS’ EQUITY    
Preferred Stock, $0.0001 par value; 20,000,000 shares authorized, 200 and 200 shares issued and outstanding 0 0
Common stock, $0.0001 par value; 20,000,000,000 shares authorized, 536,029,662 and 24,981,619 shares issued and outstanding, respectively 53,602 2,497
Common stock payable 100,000 100,000
Additional paid-in-capital 16,754,309 16,313,035
Accumulated deficit (20,187,465) (21,641,402)
Total Stockholders’ Equity (3,279,554) (5,225,870)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 2,792,971 $ 2,743,929